The University of Oxford has initiated human trials for the first COVID-19 vaccine in Europe, according to the BBC.
For story suggestions or custom animation requests, contact tips@nextanimation.com.tw.
Visit http://archive.nextanimationstudio.com to view News Direct's complete archive of 3D news animations.
RESTRICTIONS: Broadcast: NO USE JAPAN, NO USE TAIWAN Digital: NO USE JAPAN, NO USE TAIWAN The University of Oxford has initiated human trials for the first COVID-19 vaccine in Europe, according to the BBC.
Citing the university, BBC reports on April 23 that the experimental COVID-19 vaccine takes the coronavirus's genetic material and inserts the substance into adenoviruses that are responsible for the common cold.
The cold viruses are weakened so that they cannot grow inside the human body after injection.
The modified viruses should make the human cells produce the same spike proteins that stud the surface of the coronaviruses and teach the immune system to recognize COVID-19.
When vaccine recipients actually encounter the coronavirus, their bodies' immune system would then be able to identify the threat and scramble antibodies and killer T cells to fight off the infection.
At the time of report, two volunteers have received the shot, out of around 800 recruited for the first phase human trial.
Citing the doctors, the BBC reports potential side effects include headache, fever and muscle pains a couple of days after the injection.
RUNDOWN SHOWS: 1.
Experimental vaccine utilizes neutralized adenoviruses 2.
Vaccine induces the body to produce coronavirus spike proteins 3.
The immune system learns to recognize and fight the coronavirus 4.
Potential side effects include headache, fever and muscle pains VOICEOVER (in English): "Citing the University of Oxford, the BBC reports on April 23 that the experimental COVID-19 vaccine takes the coronavirus's genetic material and inserts the substance into adenoviruses that are responsible for the common cold." "The cold viruses are weakened so that they cannot grow inside the human body after injection." "The modified viruses should make the human cells produce the same spike proteins that stud the surface of the coronaviruses and teach the immune system to recognize COVID-19." "When vaccine recipients actually encounter the coronavirus, their bodies' immune system would then be able to identify the threat and scramble antibodies and killer T cells to fight off the infection." "At the time of report, two volunteers have received the shot, out of around 800 recruited for the first phase human trial." "Citing the doctors, the BBC reports potential side effects include headache, fever and muscle pains a couple of days after the injection." SOURCES: BBC https://www.bbc.com/news/health-52394485 *** For story suggestions please contact tips@nextanimation.com.tw For technical and editorial support, please contact: Asia: +61 2 93 73 1841 Europe: +44 20 7542 7599 Americas and Latam: +1 800 738 8377
Scientists at Oxford Jenner Institute began a trial involving 1,100 people last week, which they will expand to 6,000 in May.
An Oxford University vaccine will soon begin human testing.
